AEON

Companies
Nyse American
Aeon Biopharma Inc.
Health Care
Price Chart
Overview

About AEON

AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.

Market Cap
$65.7M
Volume
498.5K
Avg. Volume
4.8M
P/E Ratio
-0.6037681
Dividend Yield
0.00%
Employees
6.0

Company Information

Exchange
Nyse American
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.06
Low Correlation
Volatility
High (1.00)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for AEON.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, AEON shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$65.7M
Volume498.5K
P/E Ratio-0.60
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 29, 2024
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how AEON fits into your investment strategy and portfolio diversification.

Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025